id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-4303-0003,FDA,FDA-2017-D-4303,Providing Regulatory Submissions in Electronic Format—Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling; Guidance for Industry; Availability,Notice,Notice of Availability,2020-12-28T05:00:00Z,2020,12,2020-12-28T05:00:00Z,,2020-12-28T16:56:08Z,2020-28560,0,0,09000064849cc7af
FDA-2017-D-4303-0002,FDA,FDA-2017-D-4303,Guidance for Industry REMS.eSub,Other,Guidance,2020-12-23T05:00:00Z,2020,12,2020-12-23T05:00:00Z,,2024-11-12T23:27:37Z,,1,0,09000064849c3775